These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 20195151)

  • 1. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.
    Veronesi U; Viale G; Paganelli G; Zurrida S; Luini A; Galimberti V; Veronesi P; Intra M; Maisonneuve P; Zucca F; Gatti G; Mazzarol G; De Cicco C; Vezzoli D
    Ann Surg; 2010 Apr; 251(4):595-600. PubMed ID: 20195151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.
    Zavagno G; De Salvo GL; Scalco G; Bozza F; Barutta L; Del Bianco P; Renier M; Racano C; Carraro P; Nitti D;
    Ann Surg; 2008 Feb; 247(2):207-13. PubMed ID: 18216523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
    J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentric breast cancer: a new indication for sentinel node biopsy--a multi-institutional validation study.
    Knauer M; Konstantiniuk P; Haid A; Wenzl E; Riegler-Keil M; Pöstlberger S; Reitsamer R; Schrenk P
    J Clin Oncol; 2006 Jul; 24(21):3374-80. PubMed ID: 16849751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
    Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
    Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection.
    Veronesi U; Galimberti V; Mariani L; Gatti G; Paganelli G; Viale G; Zurrida S; Veronesi P; Intra M; Gennari R; Rita Vento A; Luini A; Tullii M; Bassani G; Rotmensz N
    Eur J Cancer; 2005 Jan; 41(2):231-7. PubMed ID: 15661547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of breast cancer patients treated with sentinel node biopsy in Japan.
    Imoto S; Wada N; Murakami K; Hasebe T; Ochiai A; Ebihara S
    Jpn J Clin Oncol; 2004 Aug; 34(8):452-6. PubMed ID: 15371462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sentinel node biopsy for breast cancer patients at the Bács-Kiskun County Teaching Hospital].
    Cserni G; Rajtár M; Boross G; Sinkó M; Svébis M; Baltás B; Ambrózay E; Szúcs M
    Orv Hetil; 2002 Mar; 143(9):437-46. PubMed ID: 12013684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].
    Martel P; Capdet J; Méry E; Zerdoud S; Ferron G; Rafii A; Roché H; Querleu D
    Bull Cancer; 2008; 95(7):763-72. PubMed ID: 18755653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer.
    Konstantiniuk P; Schrenk P; Reitsamer R; Koeberle-Wuehrer R; Tausch C; Roka S; Riedl O; Poestlberger S; Hecke D; Janauer M; Haid A
    Breast; 2007 Oct; 16(5):520-6. PubMed ID: 17566737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The feasibility of sentinel node biopsy in the previously treated breast.
    Koizumi M; Koyama M; Tada K; Nishimura S; Miyagi Y; Makita M; Yoshimoto M; Iwase T; Horii R; Akiyama F; Saga T
    Eur J Surg Oncol; 2008 Apr; 34(4):365-8. PubMed ID: 17532172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph-node biopsy compared to axillary lymph-node dissection for axillary staging in breast cancer patients.
    Schrenk P; Shamiyeh A; Wayand W
    Eur J Surg Oncol; 2001 Jun; 27(4):378-82. PubMed ID: 11417984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
    Sanuki N; Takeda A; Amemiya A; Ofuchi T; Ono M; Ogata H; Yamagami R; Hatayama J; Eriguchi T; Kunieda E
    Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
    Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.